CAMB/MAT2203 in Patients With Mucocutaneous Candidiasis

NCT02629419 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

4

Enrollment

INDUSTRY

Sponsor class

Conditions

Candidiasis, Chronic Mucocutaneous

Interventions

DRUG: Amphotericin B

Sponsor

Matinas BioPharma Nanotechnologies, Inc.